12:00 AM
 | 
Jun 18, 2012
 |  BC Week In Review  |  Company News  |  Deals

Bio-Matrix Scientific, Oregon Health & Science University deal

The university granted Bio-Matrix's Regen BioPharma Inc. subsidiary an exclusive, six-month option to license exclusive, worldwide rights to U.S. Patent No. 6,821,513 covering methods of stimulating blood...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >